Interstitial Cystitis Drugs Market, By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Geography

Description

The global interstitial cystitis drugs market is estimated to be valued at US$ 234.9 million in 2023 and is expected to exhibit a CAGR of 6.9% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 234.9 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.90%	2030 Value Projection:	US$ 375.6 Mn

Figure 1. Global Interstitial Cystitis Drugs Market Share (%), By Drug Class, 2023

Interstitial Cystitis Drugs Market - IMG1

Interstitial cystitis (IC), also known as painful bladder syndrome, is a condition that results in recurring discomfort or pain in the bladder and the surrounding pelvic area. The symptoms can differ between cases and even within the same person.People may experience mild discomfort, pressure, tenderness, or intense pain in the bladder and pelvic area. Symptoms may include an urgent need to urinate, a frequent need to urinate, or a combination of these symptoms. Pain may change in intensity as the bladder fills with urine or as it empties. Women's symptoms often get worse during menstruation. They may sometimes experience pain during vaginal intercourse.

In interstitial cystitis or painful bladder syndrome, the bladder wall may be irritated and become scarred or stiff. Hunner's ulcers, patches of broken skin found on the bladder wall, are present in 10 percent of people with IC. While some people with IC or PBS find that their bladder cannot hold much urine, which increases the frequency of urination.

Market Dynamics

Rising research and development activities for the treatment of patients suffering from interstitial cystitis are expected to propel market growth over the forecast period. For instance, on April 10, 2023, Centre Hospitalier Universitaire Vaudois, a university hospital in Lausanne, Switzerland, in collaboration with researchers of the University Hospital based in Bern, Switzerland, announced the initiation of a clinical trial study to evaluate the impact of preoperative oral immunonutrition (IN) on post-operative complications in patients undergoing interstitial cystitis and painful bladder syndrome, which is currently in phase 3 and actively recruiting patients.

Key features of the study:

This report provides an in-depth analysis of the global interstitial cystitis drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global interstitial cystitis drugs market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AbbVie Inc., Hyloris Pharmaceuticals SA, TAGCyx Biotechnologies, KYORIN Pharmaceutical Co., Ltd., PureTech Health, Vaneltix, Red Leaf Medical Inc., Bayer AG, Eli Lilly and Co, Johnson & Johnson (Janssen Pharmaceuticals), Mylan NV (Viatris Inc.), Perrigo Co. Plc, Pfizer Inc., Seikagaku Corp., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and ImprimisRx (Harrow Health, Inc.)
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global interstitial cystitis drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interstitial cystitis drugs market

Interstitial Cystitis Drugs Market Detailed Segmentation:

By Drug Class:
- Non-steroidal Anti-inflammatory Drugs
- Tricyclic Antidepressants
- Pentosan Polysulfate Sodium (Elmiron)
- Dimethyl Sulfoxide (DMSO)
- Others (Anti-histamines, etc.)
By Type:
- Non-ulcerative
- Ulcerative
By Route of Administration:
- Oral
- Intravesical
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Company Profiles
- AbbVie Inc.
- Hyloris Pharmaceuticals SA
- TAGCyx Biotechnologies
- KYORIN Pharmaceutical Co., Ltd.
- PureTech Health
- Vaneltix
- Red Leaf Medical Inc.
- Bayer AG
- Eli Lilly and Co.
- Johnson & Johnson (Janssen Pharmaceuticals)
- Mylan NV (Viatris Inc.)
- Perrigo Co. Plc
- Pfizer Inc.
- Seikagaku Corp.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- ImprimisRx (Harrow Health, Inc.)

Product Code: CMI4488

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities
- Impact Analysis
- Recent Drug Launch with Historic Roadmap
- Epidemiology
- Pipeline Analysis
- Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis

4. Global Interstitial Cystitis Drugs Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Interstitial Cystitis Drugs Market, By Drug Class, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Non-steroidal Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Tricyclic Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Pentosan Polysulfate Sodium (Elmiron)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Dimethyl Sulfoxide (DMSO)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Others (Anti-histamines, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends

6. Global Interstitial Cystitis Drugs Market, By Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Non-ulcerative
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Ulcerative
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends

7. Global Interstitial Cystitis Drugs Market, By Route of Administration, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Intravesical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends

8. Global Interstitial Cystitis Drugs Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

9. Global Interstitial Cystitis Drugs Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/ Region, 2018-2030, (US$ Mn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Company Profiles
- AbbVie Inc.*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Hyloris Pharmaceuticals SA
- TAGCyx Biotechnologies
- KYORIN Pharmaceutical Co., Ltd.
- PureTech Health
- Vaneltix
- Red Leaf Medical Inc.
- Bayer AG
- Eli Lilly and Co.
- Johnson & Johnson (Janssen Pharmaceuticals)
- Mylan NV (Viatris Inc.)
- Perrigo Co. Plc
- Pfizer Inc.
- Seikagaku Corp.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- ImprimisRx (Harrow Health, Inc.)

11. Section

References
Research Methodology
About us and Sales Contact